Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine

Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine

Blood biomarkers, including neurofilament light chain (NfL), have garnered attention as potential indicators for chemotherapy-induced peripheral neuropathy (CIPN), a dose-limiting adverse effect of neurotoxic anticancer drugs. However, no blood biomarker has been established for routine application...

Full description

Bibliographic Details
Main Authors: David Balayssac, Julie Durif, Céline Lambert, Cristelle Dalbos, Eric Chapuy, Monique Etienne, Claire Demiot, Jérôme Busserolles, Vincent Martin, Vincent Sapin
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Toxics
Subjects:
chemotherapy-induced peripheral neuropathy
oxaliplatin
paclitaxel
bortezomib
vincristine
animal model
Online Access:https://www.mdpi.com/2305-6304/11/12/1004

Internet

https://www.mdpi.com/2305-6304/11/12/1004

Similar Items